期刊文献+

茶多酚对舌鳞状细胞癌细胞增殖和端粒酶催化亚基的抑制作用 被引量:8

Effects of tea polyphenols on cell proliferation and hTERT of human Tca8113 cell lines
原文传递
导出
摘要 目的观察茶多酚对人舌鳞状细胞癌Tca8113细胞增殖和端粒酶催化亚基(hTERT)的影响。方法实验分0.025、0.050、0.100、0.200g/L茶多酚组和空白培养基组。采用噻唑蓝比色法检测茶多酚对Tca8113细胞增殖的影响,逆转录PCR法检测hTERT基因表达,Western-blot法测定细胞中hTERT蛋白表达量。所有数据采用ANOVA单因素方差分析和Student-Newman-Keuls检验进行统计学检验。结果茶多酚能明显抑制Tca8113细胞增殖,并存在时间和浓度依赖性。72h时,0.200、0.100、0.050和0.025g/L茶多酚组细胞增殖抑制率分别为69.75%±3.24%、63.17%±3.19%、50.35%±4.21%和34.75%±3.71%。72h时,0.100、0.050g/L组hTERT mRNA和蛋白表达均低于空白对照组(P<0.05)。结论茶多酚能够抑制人舌鳞状细胞癌Tca8113细胞株的增殖及端粒酶催化亚基的转录和表达,抑制端粒酶催化亚基可能是茶多酚抗舌癌的机制之一。 Objective To investigate the effects of tea polyphenols (TP) on cell proliferation and human telomerase reverse transcriptase (hTERT). Methods The experiment was divided into tea polyphenols 0.100g/L , tea polyphenols 0. 050g/L and blank control groups. The inhibitory ratio of cell proliferation was assayed with MTT, and hTERT mRNA was detected by RT-PCR, and hTERT protein analyzed by Western-blotting. The data were analyzed by one-way ANOVA and Student-Newman-Keuls of SPSS 11.0 for windows. Results Cell proliferations were significantly inhibited after exposure to TP. The proliferation inhibiting rate of TP 0. 025, 0. 050, 0. 100,0. 200 g/L on Tca8113 cell at 72 h was 69. 75%±3.24%,63.17%±3.19%,50.35%±4.21% and 34. 75%±3.71%,respectively(F=270.19, P〈0. 05). At the end of 72 h, the hTERT mRNA expression in TP 0. 100 g/L, 0. 050 g/L and control group were 0. 32±0. 05, 0.41±0. 04, 0. 72±0. 05, respectively( P〈0.05 ). The Western-blotting assay showed that hTERT protein was also decreased by tea polyphenols compared to control group. Conclusions Tea polyphenols could inhibit the proliferation of Tca8113 cells and expression of the hTERT mRNA and protein in Tca8113 cell lines. This effect might be one of the mechanisms for anticancer function of tea polyphenols.
出处 《中华口腔医学杂志》 CAS CSCD 北大核心 2005年第6期451-454,共4页 Chinese Journal of Stomatology
关键词 鳞状细胞 肿瘤细胞 培养的 茶多酚 Carcinoma, squamous cell Tumor cells,cultured Tea polyphenols
  • 相关文献

参考文献10

二级参考文献17

  • 1James WT, Cohen S, Charles AB, et al. Summary of the Ⅲ international consensus symposium on combined antiviral therapy. Antiviral Research, 1998,38(2):75-93. 被引量:1
  • 2Christoph S, Robert GW. Long-term stability of the anti-influenza a compounds-amantadine and rimantadine[J].Antiviral Research, 1998, 38(3): 213-215. 被引量:1
  • 3Mao L,Cancer Res,1996年,56卷,5600页 被引量:1
  • 4Shay JW, Gazdar AF.Asurvey of telomerase activity in human cancer. Eur J Cancer, 1997, 33:787-791. 被引量:1
  • 5Ide T, Takara H, Nakashio M, et al. Telomerase in hepatocellular carcinogenesis. Hum Cell, 1996, 9:283-286. 被引量:1
  • 6Greider CW, Blackburn EH. A telomere sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature, 1989, 337:331-337. 被引量:1
  • 7Bodnar AG, Ouellette M, Frolkis M, et al. Extention of life-span by introduction of telomerase into normal human cells. Science, 1998, 279: 334-335. 被引量:1
  • 8Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science, 1994, 266: 2011-2015. 被引量:1
  • 9Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol, 1996, 8: 66-71. 被引量:1
  • 10Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res, 1997, 25: 2595-2597. 被引量:1

共引文献57

同被引文献150

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部